Slowly progressive type 1 neovascularization mimicking drusenoid retinal pigment epithelium elevation

Retina

Volumn 35, Issue 12, 2015, Pages 2433-2439

  Querques, Giuseppe ^a,b   Souied, Eric H ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN;

AGE RELATED MACULAR DEGENERATION; B SCAN; BASEMENT MEMBRANE; BRUCH MEMBRANE; DRUSEN; DRUSENOID RETINAL PIGMENT EPITHELIUM ELEVATION; FLUORESCENCE ANGIOGRAPHY; GEOGRAPHIC ATROPHY; HUMAN; MACROPHAGE; MINERALIZATION; MULTIMODAL IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIUM; RETINA DETACHMENT; REVIEW; SUBRETINAL NEOVASCULARIZATION; VISUAL IMPAIRMENT; DISEASE COURSE; MACULAR DEGENERATION; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; RETINAL PIGMENT EPITHELIUM;

DISEASE PROGRESSION; HUMANS; MACULAR DEGENERATION; NEOVASCULARIZATION, PATHOLOGIC; RETINAL DRUSEN; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84948583660     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000761     Document Type: Review

References (25)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82:844-851.
2. Hageman GS, Mullins RF. Molecular composition of drusen as related to substructural phenotype. Mol Vis 1999;5:28.
3. Russell SR, Mullins RF, Schneider BL, Hageman GS. Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. Am J Ophthalmol 2000;129:205-214.
4. Rudolf M, Clark ME, Chimento MF, et al. Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest Ophthalmol Vis Sci 2008;49:1200-1209.
5. Bressler NM, Silva JC, Bressler SB, et al. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina 1994;14:130-142.
6. Spaide RF, Curcio CA. Drusen characterization with multimodal imaging. Retina 2010;30:1441-1454.
7. Ferris FL, Davis MD, Clemons TE, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 2005;123:1570-1574.
8. Seddon JM, Sharma S, Adelman RA. Evaluation of the clinical age-related maculopathy staging system. Ophthalmology 2006; 113:260-266.
9. Pauleikhoff D, Barondes MJ, Minassian D, et al. Drusen as risk factors in age-related macular disease. Am J Ophthalmol 1990; 109:38-43.
10. Klein R, Klein BE, Knudtson MD, et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007;114:253-262.
11. Hyman L, Neborsky R. Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol 2002;13: 171-175.
12. Gass JD. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1994;118:285-298.
13. Gass JD. Stereoscopic Atlas of Macular Diseases. 4th ed. St Louis, MO: C. V. Mosby; 1997:26-30.
14. Sallo FB, Rechtman E, Peto T, et al. Functional aspects of drusen regression in age-related macular degeneration. Br J Ophthalmol 2009;93:1345-1350.
15. Smith RT, Sohrab MA, Pumariega N, et al. Dynamic soft drusen remodelling in age-related macular degeneration. Br J Ophthalmol 2010;94:1618-1623.
16. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye 1988;2:552-577.
17. Querques G, Georges A, Ben Moussa N, et al. Appearance of regressing drusen on optical coherence tomography in age-related macular degeneration. Ophthalmology 2014;121:173-179.
18. Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol 2009;147:825 644-652.
19. Querques G, Srour M, Massamba N, et al. Functional characterization and multimodal imaging of treatment-naive quiescent choroidal neovascularization. Invest Ophthalmol Vis Sci 2013;54:6886-6892.
20. Querques G, Souied EH, Freund KB. How has highresolution multimodal imaging refined our understanding of the vasogenic process in type 3 neovascularization? Retina 2015;35:603-613.
21. Wu Z, Luu CD, Ayton LN, et al. Optical coherence tomography defined changes preceding the development of drusenassociated atrophy in age-related macular degeneration. Ophthalmology 2014;121:2415-2422.
22. Schachat AP, Thompson JT. Optical coherence tomography, fluorescein angiography, and the management of neovascular age-related macular degeneration. Ophthalmology 2015;122: 222-223.
23. Castillo MM, Mowatt G, Elders A, et al. Optical coherence tomography for the monitoring of neovascular age-related macular degeneration: a systematic review. Ophthalmology 2015;122:399-406.
24. Yehoshua, Wang F, Rosenfeld PJ, et al Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology 2011;118:2434-2441
25. Garcia Filho CA, Yehoshua Z, Gregori G, et al. Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina 2014;45:18-31.